A five-year review of Pseudomonas aeruginosa bacteremia in children hospitalized at a single center in southern China

Keyphrases

• All Pediatric 8%
• Antibiotic Coverage 8%
• Antibiotic Sensitivity 8%
• Antibiotic Susceptibility 8%
• Antibiotic Therapy 8%
• Aspartate Aminotransferase 8%
• Bacteremia 58%
• Case Fatality Rate 16%
• Child Hospitalized 100%
• Clinical Outcomes 8%
• Community-acquired 16%
• Empiric Antibiotics 8%
• Fatal Case 16%
• Gastrointestinal 16%
• Graves 8%
• Healthy children 8%
• Healthy Young 8%
• Hypotension 8%
• Illness 8%
• Immune Defense 8%
• Initial Antibiotics 16%
• Leukopenia 16%
• Multiresistant 8%
• One-child 8%
• Pediatric 8%
• Pediatric Case 8%
• Poor Outcome 8%
• Positive Blood Culture 8%
• Prealbumin 8%
• Pseudomonas Aeruginosa (P. aeruginosa) 100%
• Pseudomonas Aeruginosa Bacteraemia 100%
• Retrospective Cohort Study 8%
• Risk Factors 8%
• Seizure 16%
• Single Center 100%
• Southern China 100%
• Therapy Outcome 8%
• Underlying Disease 8%
• Young children 8%

Pharmacology, Toxicology and Pharmaceutical Science

• Antibiotic Agent 7%
• Antibiotic Therapy 7%
• Antibiotics 28%
• Aspartate Aminotransferase 7%
• Bacteremia 100%
• Case Fatality Rate 14%
• Cohort Study 7%
• Disease 14%
• Fatality 14%
• Hypotension 7%
• Leukopenia 14%
• Pseudomonas aeruginosa 100%
• Transthyretin 7%